Waitzfelder, Beth
Palaniappan, Latha
Varga, Alexandra
Frankland, Timothy B.
Li, Jiang
Daida, Yihe G.
Kaholokula, Joseph Keawe’aimoku
Bacong, Adrian Matias
Rawlings, Andreea M.
Chung, Sukyung
Howick, Connor
Fortmann, Stephen P.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute, National Institutes of Health (HL 126172, HL 126172, HL 126172, HL 126172, HL 126172, HL 126172, HL 126172, HL 126172, HL 126172, HL 126172)
National Center for Advancing Translational Sciences, National Institutes of Health, Award Number (1UL1TR003142, 1UL1TR003142, 1UL1TR003142, 1UL1TR003142)
Article History
Received: 2 September 2022
Accepted: 3 May 2023
First Online: 15 May 2023
Declarations
:
: The study was conducted with the approval and oversight of Institutional Review Boards at Kaiser Permanente Hawai’i (KPHI) and the Palo Alto Medical Foundation (PAMF). All methods were carried out in accordance with relevant guidelines and regulations for the protection of human subjects in research. Electronic health records were accessed under a waiver of authorization from the review boards and confidentiality was fully maintained throughout the study. Informed consent was obtained from all subjects or their legal guardian(s) for the surveys administered to a subgroup.
: Not applicable.
: The authors declare no competing interests.